Since the discovery of elevated concentrations of TGFβ2 in the eyes of POAG patients in 1994, this profibrotic messenger has been widely considered to be the key driving factor in the pathology of the TM seen in POAG (48, 49). Here, TGFB2 is linked to open-angle glaucoma.